| 05/05/2026 7:32 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 7:33 AM | Disc Medicine (1816736) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/28/2026 4:20 PM | Disc Medicine (1816736) Filer | Form ARS | |
| 04/28/2026 4:02 PM | Disc Medicine (1816736) Filer | Form DEF 14A | |
| 04/28/2026 4:06 PM | Disc Medicine (1816736) Filer | Form DEFA14A | |
| 04/15/2026 3:53 PM | Disc Medicine (1816736) Issuer Franchi Jean M. (1653053) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 4:05 PM | Disc Medicine (1816736) Issuer Savage William Jacob (1951852) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 3:37 PM | Disc Medicine (1816736) Subject Savage William Jacob (1951852) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 3:55 PM | Disc Medicine (1816736) Issuer Savage William Jacob (1951852) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:32 PM | Disc Medicine (1816736) Subject Savage William Jacob (1951852) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 8:16 AM | Disc Medicine (1816736) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for IRON and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Disc Medicine and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/26/2026 7:32 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 7:36 AM | Disc Medicine (1816736) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/25/2026 3:29 PM | Disc Medicine (1816736) Subject Franchi Jean M. (1653053) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 4:42 PM | Disc Medicine (1816736) Issuer Franchi Jean M. (1653053) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 3:41 PM | Disc Medicine (1816736) Subject Franchi Jean M. (1653053) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 8:20 PM | Disc Medicine (1816736) Issuer Khara Rahul (1951850) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 8:03 PM | Disc Medicine (1816736) Issuer Quisel John D (1586788) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 8:05 PM | Disc Medicine (1816736) Issuer Yu Jonathan Yen-Wen (1951849) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 8:09 PM | Disc Medicine (1816736) Issuer Savage William Jacob (1951852) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 8:15 PM | Disc Medicine (1816736) Issuer Stephenson Pamela (1767650) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:46 PM | Disc Medicine (1816736) Subject Yu Jonathan Yen-Wen (1951849) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:51 PM | Disc Medicine (1816736) Subject Savage William Jacob (1951852) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:54 PM | Disc Medicine (1816736) Subject Stephenson Pamela (1767650) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:57 PM | Disc Medicine (1816736) Subject Khara Rahul (1951850) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:38 PM | Disc Medicine (1816736) Subject Quisel John D (1586788) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:43 PM | Disc Medicine (1816736) Subject Franchi Jean M. (1653053) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 6:42 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 6:46 PM | Disc Medicine (1816736) Issuer Stephenson Pamela (1767650) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 6:50 PM | Disc Medicine (1816736) Issuer Khara Rahul (1951850) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 6:34 PM | Disc Medicine (1816736) Issuer Yu Jonathan Yen-Wen (1951849) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 6:40 PM | Disc Medicine (1816736) Issuer Savage William Jacob (1951852) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 6:26 PM | Disc Medicine (1816736) Issuer Franchi Jean M. (1653053) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 6:12 PM | Disc Medicine (1816736) Issuer Quisel John D (1586788) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:55 PM | Disc Medicine (1816736) Issuer Khara Rahul (1951850) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:37 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 3:53 PM | Disc Medicine (1816736) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13G | |
| 01/05/2026 7:02 PM | Disc Medicine (1816736) Issuer Khara Rahul (1951850) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:30 PM | Disc Medicine (1816736) Subject Khara Rahul (1951850) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 7:50 PM | Disc Medicine (1816736) Issuer Savage William Jacob (1951852) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 5:16 PM | Disc Medicine (1816736) Issuer Quisel John D (1586788) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 12/18/2025 5:14 PM | Bitterman Kevin (1591747) Reporting Disc Medicine (1816736) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 7:07 PM | Atlas Venture Fund X, L.P. (1628098) Filed by Disc Medicine (1816736) Subject | Form SCHEDULE 13D/A | |
| 12/17/2025 6:48 PM | AI DMI LLC (1890993) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/17/2025 4:05 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/17/2025 4:06 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/17/2025 4:07 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/17/2025 4:08 PM | Atlas Venture Fund XII, L.P. (1812049) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 8:43 PM | Bitterman Kevin (1591747) Reporting Disc Medicine (1816736) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 8:31 PM | Disc Medicine (1816736) Issuer Savage William Jacob (1951852) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:27 PM | AI DMI LLC (1890993) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:15 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:16 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:17 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:18 PM | Atlas Venture Fund XII, L.P. (1812049) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:18 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 4:03 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:56 PM | Atlas Venture Associates XII, L.P. (1845875) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:59 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 6:52 PM | AI DMI LLC (1890993) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:50 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:56 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:56 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 5:44 PM | Atlas Venture Associates XII, L.P. (1845875) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 4:40 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 4:45 PM | Bitterman Kevin (1591747) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 4:49 PM | Disc Medicine (1816736) Issuer Quisel John D (1586788) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 4:34 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 4:35 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 4:37 PM | Atlas Venture Fund XII, L.P. (1812049) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 3:14 PM | Disc Medicine (1816736) Subject Savage William Jacob (1951852) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 8:50 PM | AI DMI LLC (1890993) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 4:10 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 4:11 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 4:13 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 4:15 PM | Atlas Venture Fund XII, L.P. (1812049) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 3:25 PM | Disc Medicine (1816736) Subject Quisel John D (1586788) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/08/2025 7:40 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2025 7:22 PM | Disc Medicine (1816736) Issuer Yu Jonathan Yen-Wen (1951849) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2025 5:56 AM | Disc Medicine (1816736) Subject Yu Jonathan Yen-Wen (1951849) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/06/2025 7:33 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 7:34 AM | Disc Medicine (1816736) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 10:30 AM | Disc Medicine (1816736) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G/A | |
| 10/24/2025 3:01 PM | Access Industries Holdings LLC (1391297) Reporting ACCESS INDUSTRIES MANAGEMENT, LLC (1508226) Reporting AI DMI LLC (1890993) Reporting Blavatnik Len (1326628) Reporting Disc Medicine (1816736) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 8:44 PM | AI DMI LLC (1890993) Filed by Disc Medicine (1816736) Subject | Form SCHEDULE 13D/A | |
| 10/22/2025 8:11 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2025 4:13 PM | Disc Medicine (1816736) Filer | Form 424B5 | |
| 10/20/2025 7:54 PM | Disc Medicine (1816736) Subject ORBIMED ADVISORS LLC (1055951) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/20/2025 7:47 PM | Disc Medicine (1816736) Subject ORBIMED ADVISORS LLC (1055951) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/20/2025 7:52 PM | Disc Medicine (1816736) Subject ORBIMED ADVISORS LLC (1055951) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/20/2025 6:09 AM | Disc Medicine (1816736) Filer | Form 424B5 | |
|
| 10/20/2025 5:38 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 4:23 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/17/2025 4:26 PM | Atlas Venture Opportunity Fund II, L.P. (1885327) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/17/2025 3:41 PM | Bitterman Kevin (1591747) Reporting Disc Medicine (1816736) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/17/2025 3:42 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/17/2025 7:43 AM | Disc Medicine (1816736) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/16/2025 3:46 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/16/2025 3:46 PM | Atlas Venture Fund X, L.P. (1628098) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/15/2025 4:00 PM | Atlas Venture Opportunity Fund I, L.P. (1759241) Reporting Disc Medicine (1816736) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |